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Despite a high likelihood of immediate success, all
lower-extremity revascularisation procedures have a
significant rate of failure over time (see also B 4.4,
Surgery for Intermittent Claudication, p 597). It is
now well recognised that patency of the treated arteri-
al segment is most effectively preserved through sur-
veillance programs that are capable of identifying
flow-limiting lesions before complete occlusion of the
conduit or vessel. l ,2,3,4 Revision of failing reversed
saphenous vein bypass grafts, for example, results in
excellent long-term graft function, with assisted pri-
mary patencies of 82% to 92% at 5 years.w Once com-
plete occlusion has occurred, thrombectomy and revi-
sion yields a poorer secondary patency of only 43% to
76% at 5 years,7,s,9 Similarly, the treatment of complete
re-occlusions of angioplasty sites has a lower likeli-
hood of technical success, a higher incidence of com-
plications, and yields a less durable result. IO,1I
Clearly, the identification and treatment of flow-lim-
iting lesions within the treated arterial segment before
thrombosis of the segment provides a more durable
result. Surveillance programs, therefore, represent a
potentially valuable adjunct to every type of vascular
intervention performed for the preservation of lower
extremity perfusion. Because not all peripheral inter-
ventions are easily evaluated, the methods that pro-




A number of methods of posttreatment surveillance of
patients undergoing lower extremity revascularisation
have been practised over the past several decades.
These include clinical examination, ankle.brachial
indices, duplex imaging, and arteriography.
Additional study methods have been used, such as
segmental pressures and plethysmography, but little
information exists regarding the utility of these tech-
nologies.
Patient historyand clinical examination
Most patients (66%) who have undergone
femoropopliteal or femorotibial bypass procedures
experience a return of preoperative symptoms imme-
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diately on graft occlusion.t? Unfortunately, few of
these patients develop slowly progressive symptoma-
tology during the development of flow-limiting or
graft-threatening lesions.'! This is especially true of
those patients who do not participate in a postopera-
tive exercise therapy program and remain sedentary.
Therefore, although patient history is an essential and
valuable source of information, alone it is of little
value in detecting the development and evolution of
luminal lesions capable of causing graft thrombosis.
Physical examination also lacks sufficient sensitivi-
ty for the detection of failing grafts or angioplasty
sites.J4,15 Isolated stenoses of inflow or outflow vessels
or of a graft infrequently alter physical examination.
Similarly, pulse examination of the patient at rest and
the appearance of the foot may not be changed by the
presence of a significant isolated stenosis.w Graft
occlusion occurs in many patients before the onset of
symptoms or alteration in the quality and character of
peripheral pulses. Therefore, clinical history and
physical examination are inadequate as the sole com-
ponents for graft surveillance and the reliable detec-
tion of failing femoropopliteal or femorotibial bypass
grafts. Patient history and physical examination
remain, however, essential components of any surveil-
lance program.
Anklebrachial pressllre indices
The use of resting ABPI for the detection of haemody-
namically significant arterial occlusive disease has
been uniformly accepted, although they may be sub-
ject to measurement variability and study limitations.
Individual recordings of ABPI in a patient may vary
by as much as 0.1 without a fixed reduction in periph-
eral blood flow. A decrease in index of 0.15, the para-
meter most widely used as representative of a signifi-
cant reduction in blood flow, requires the develop-
ment of a haemodynamically significant stenosis of at
least 50%)7 These high-grade stenoses are more likely
to undergo sudden thrombotic occlusion. The inabili-
ty to identify mild or moderate flow-reducing lesions
prevents the recording of slowly falling ABPI in
patients with an evolving graft-related stenosis.w'?
Additionally, resting ABPI may be falsely elevated in
patients with calcified distal arteries and may be of
limited value in patients who did not normalise their
ABPI in the immediate postoperative period. These
factors limit the usefulness of the resting ABPI for the
detection of failing lower extremity revascularisa-
tions.
One group of investigators has documented equiv-
alent graft failure rates in patients with haerno-
dynamically significant drops in resting ABPI (>0.2)
and those with stable ABPJ.1s Similarly, another group
has shown that a decrease in resting ABPI of 0.2 did
not distinguish between patients who proceeded to
graft occlusion and those who did no1.19 For these rea-
sons, the resting ABPI cannot reliably provide the
physician with information regarding the develop-
ment of stenoses and the probability of a thrombotic
episode within angioplasty sites or bypass grafts.
Toe.brachial indices provide no better discrimina-
tion .>' The measurement of post-exercise ABPI may
improve the detection of flow-limiting stenoses. A
well-recognised method for enhancing the detection
of subcritical stenoses in native vessels, post-exercise
ankle-brachial indices have been shown to be of
greater value than resting ABPI for the identification
of failing lower extremity angioplasty," A recent appli-
cation of this form of ABPI assessment showed that a
significant number of patients with significant graft
stenoses experienced a reduction in post-exercise
ABPI despite an unchanged resting ABPI.22 Thus, the
post-exercise ABPI may be helpful in the detection of
suprainguinal reconstructions or lower extremity
angioplasty procedures.
Colour flow duplexscanning
Colour flow duplex scanning has been widely used in
surveillance programs because of its simplified ability
to identify stenoses in native arteries and vein grafts.
Colour guidance has reduced the amount of time
required to locate significant lesions within autoge-
nous grafts and, therefore, has made rapid scanning of
the entire graft length in the lower extremity feasible.
Scans can be performed longitudinally and can detect
a variety of conditions that may impact on graft func-
tion, including persistent arteriovenous fistulae, com-
pressive haematoma, kinks or other forms of graft
mal positioning, and pseudoaneurysms. .
A graft can be evaluated at each anastomosis and
throughout its length. Areas of concern can be re-
examined at frequent intervals if clinically indicated to
identify the extent and rate of development of stenotic
lesions. Duplex surveillance of lower extremity vein
grafts is more easily accomplished than prosthetic
grafts because of the ability to completely scan the
graft and identify areas of stenosis and altered flow
rates. The flow surface contours of a normal vein graft
should be smooth and parallel on longitudinal scan. A
recent study has shown that baseline graft peak flow
velocities vary with the site of distal anastomosis
(popliteal vs tibial) and quality of outflow tract.P Vein
grafts to the popliteal artery had a mean peak flow
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.velocity of 89.5 cm/s, whereas those to the tibial ves-
sels had a mean peak flow velocity of 64 cm/s.
Although criteria for graft failure vary among labo-
ratories, there are general guidelines for detection of
the failing distal graft. These include an increase in
peak systolic velocity to greater than 150 cm/s, a peak
systolic velocity ratio of greater than 2.0 across a
stenosis, and a reduction in peak systolic velocity to
less than 45 cm/s. Because luminal diameter is nar-
rowed within a native artery or autogenous graft,
peak systolic velocities within the lesion increase. A
peak systolic velocity of 150 to 170 cm/s correlates
with a greater than 50% diameter reduction." A peak
systolic velocity of 180 cm/s or greater suggests a crit-
ical diameter reduction of 80% or more.25 As the peak
systolic velocity increases, end-diastolic velocity may
also begin to rise.
End-diastolic velocities of greater than 50 cm/s in
conjunction with high peak systolic velocities indicate
a greater than 70% loss of luminal diarneter.e A reduc-
tion of peak systolic velocity to less than 45 cm/s at the
site of the smaller of the anastomoses (proximal in
reversed vein grafts, distal in situ) suggests a proximal
flow-limiting lesion but is less specific than either peak
systolic or end-diastolic velocity measurernents.w
Because peak velocities within a vein graft may vary
from the established baseline, velocity ratios have
been used to detect the presence of significant
stenoses. The peak systolic velocity ratio is calculated
by dividing the peak systolic velocity at the site of the
stenosis by that obtained in the normal segment. A
ratio greater than 2.0 suggests the presence of a 50%
diameter-reducing lesion.27,28 An elevated peak sys-
tolic velocity ratio in conjunction with elevated peak
velocities and the identification of an anatomic lesion
on duplex image are strongly suggestive of a signifi-
cant, graft-threatening stenosis. The use of duplex
imaging for the evaluation of prosthetic bypass grafts
is more limited. Because clear luminal images fre-
quently cannot be obtained within synthetic grafts,
especially ePTFE, the benefit of duplex imaging is lim-
ited to the evaluation of the anastomoses and the
inflow and outflow vessels. The value of performing a
truncated scan such as this remains controversial.
More recently, duplex imaging has been applied to
the surveillance of transluminal angioplasty of the
lower extremity. Although the presence of significant
amounts of calcium in the arterial wall may prevent
clear visualisation of the specific angioplasty site, peak
systolic flow velocities across the site can be deter-
mined, and peak systolic velocity ratios can be calcu-
lated. These values are capable of detecting the pres-
ence of restenosis of the angioplasty site or the wors-
ening of occlusive disease in adjacent segments.1O.19
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The use of peak systolic velocities and velocity
ratios enhance the ability of colour flow duplex imag-
ing to detect mild, moderate, and severe stenoses. This
surveillance modality is capable of detecting stenoses
of less than 50%, permitting physicians to follow the
evolution of these lesions and plan appropriate thera-
py. The greatest limitation to this technique of patient
evaluation is its operator dependency. Optimal results
with colour duplex imaging for surveillance requires
an experienced technologist who can not only identify
the presence of a stenotic lesion by velocity criteria but
also provide information about the location and char-
acteristics of the lesion. It might be that MRA should
be advised if patients have heavily calcified vessels, or
if other reasons exist for ABPI being inadequate, or if
good quality colour duplex scanning either is not
available or cannot be performed adequately because
of patient habitus.
Allgiography
Angiography is well accepted as the "gold standard"
for anatomic diagnostic studies. Biplanar arteriogra-
phy is associated with high positive and negative
predictive values for the detection of stenoses within
native arteries and autogenous and prosthetic grafts.
Appropriately performed, this diagnostic test can
identify the presence, location, and severity of occlu-
sive lesion within the segment of arterial tree
imaged. Unlike the noninvasive studies, image clari-
ty does not decrease above the inguinal ligament,
and the mobility of newer imaging systems permits a
wide variety of views capable of providing signifi-
cant anatomic information. The retrograde measure-
ment of pressure gradients across iliac lesions can
contribute valuable haemodynamic information
about inflow vessels.
The morbidity and mortality of angiography,
though quite low, plus patient discomfort and cost,
make this an unacceptable routine method of sur-
veillance.w" Its role as an adjunctive diagnostic
modality to confirm noninvasive duplex findings, or
to provide additional anatomic detail about a specif-
ic stenotic lesion is, however, important.
D 4.14.3
Appropriate Use of Graft Surveillance
Overall, surveillance programs have shown the bene-
fit of duplex imaging for the detection of vein graft
stenoses that, if untreated, would result in graft occlu-
sion." Postoperatively, the development of lesions
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that threaten graft patency of saphenous vein bypass-
es occur most often within the body of the graft. In a
study of occluded and failing saphenous vein grafts,
63% of the lesions were located within the graft, and
20% were at the anastomoses.P As an easily repeated
diagnostic test with excellent patient compliance,
duplex imaging permits frequent assessment of lumi-
nal irregularities and the detection of haemodynami-
cally significant stenoses that, when corrected, help
preserve vein graft function. It has been suggested
that surveillance may be restricted to the first 6
months after operation in those patients who have a
normal bypass during that period.>' Treatment of
haemodynamically significant lesions in nonoccluded
but failing saphenous vein grafts results in primary
assisted patency rates greater than 80% at 5
years.1,2,3,4,5,6
The time of initiation of duplex imaging surveil-
lance programs varies among practising centres. Most,
however, obtain the first postoperative scan at 1 week
or before discharge. The initial scan may detect a wide
variety of graft conditions that might impact on graft
survival.v These include the identification of persist-
ent, large arteriovenous fistulae that may divert distal
flow in in situ bypasses, compressive haematoma,
anastomotic pseudoaneurysms, as well as retained
valves, adherent thrombus, and luminal flaps.
The detection of luminal pathology not discovered
in the operating room at the time of graft placement
has been reported to occur in as many as 37% of
patients, with 32% of these compromised grafts ulti-
mately requiring revision of the identified lesion."
Subsequent surveillance studies have been performed
on a wide variety of schedules. Most commonly for
patients with autogenous lower extremity bypass,
graft surveillance studies are performed at 1, 3, 6, 12,
18 and 24 months, and then yearly thereafter. The cost-
effectiveness of frequent surveillance beyond 2 years
is controversial because of the reduced incidence of
graft failure after this period. 3,36 The cost-effectiveness
of Duplex scanning during the first year has also been
questioned."
Recommendation 97: Surveillance program for vein
bypass grafts
Patients undergoing vein bypass graft placement in
the lower extremity for the treatment of claudica-
tion or limb-threatening ischaemia should be
entered into a surveillance program. This program
should consist of:
• interval history (new symptoms>
• vascular examination of the leg with palpation of
periodic measurement of resting and, if possible,
post-exercise ankle:brachial indices
• duplex scanning of the entire length of the graft,
with calculation of peak systolic velocities and
the velocity ratios across all identified lesions
Surveillance programs should be performed in the
immediate postoperative period and at regular
intervals for at least 2 years.
Critical Issue 39: Cost-effectiveness of duplex
imaging survei11ance for vein grafts
There is a need for documenting the cost-effective-
ness of using duplex imaging for vein graft surveil-
lance at all periods.
Critical Issue 40: Frequency and duration of
survei11ance in vein and prosthetic grafts
There is a need to establish optimal frequency and
duration of survei11ance testing in vein and pros-
thetic grafts.
The indications for treatment of an identified lesion
must be individualised for each specific patient.
Numerous variables impact on graft function and
limb salvage. Nonetheless, the value of a surveillance
program lies in its ability to identify for the vascular
specialist the graft threatened by flow-limiting lesions.
The impact of such lesions on long-term graft function
has been well recognised and defined.3S,39 Because
stenotic lesions causing a greater than 50% diameter
reduction are at greater risk for acute thrombosis, the
identification of such lesions should lead the vascular
specialist to consider treatment.w Prompt, definitive
evaluation of the entire graft, inflow, and outflow ves-
sels, with angiography if necessary, and intervention,
if indicated, should be undertaken. Delay in the eval-
uation and treatment of grafts at risk may result in
graft failure and a poorer prognosis for the patient.'!
Duplex imaging, however, has not been uniformly
effective for the detection of failing prosthetic grafts.42,H
Surveillance of prosthetic bypasses with duplex
imaging may not detect impending graft failure sec-
ondary to lesions within the graft. 44 Technical difficul-
ties associated with scanning of the graft, especially
those prosthetics with external support, frequently
yield suboptimal images. The benefit of surveillance
in patient with prosthetic grafts lies in the likelihood
that the graft-threatening lesion usually does not
occur within the body of the graft. Of 144 graft-threat-
ening lesions identified in 91 failing PTFE bypass
grafts, only 10 stenoses (8%) were located within the
graft. The remainder were located within the inflow
vessel (30%), outflow vessel (57%), or at an anastomo-
sis (6%).45 Other studies have shown a benefit of
duplex image surveillance for prosthetic grafts.46,47
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Though the benefit of duplex imaging alone appears
to be limited, a surveillance program for patients who
have undergone placement of a synthetic bypass graft
is indicated.
Recommendation 98: Surveillance program for
prosthetic grafts
Patients undergoing prosthetic femoropopliteal or
femorotibial bypass for claudication or limb-threat-
ening ischaemia should be entered into a graft sur-
veillance program, which consists of:
• interval history (new symptoms)
• vascular examination of the leg with palpation of
proximal, graft, and outflow vessel pulses
• ankle:brachial indices at rest and, if possible,
after exercise testing
Surveillance programs should be performed in the
immediate postoperative period and at regular
intervals for at least 2 years.
The benefit of surveillance programs for patients
who have been treated with proximal vascular recon-
struction, such as aortoiliac or iliofemoral bypass, or
transluminal angioplasty, remains controversial. Some
studies have demonstrated a benefit to surveillance
with duplex imaging.1O,29,4s Few studies have been rig-
orously performed to determine the impact of a
surveillance program on the long-term outcome of
angioplasty.
A recent study of duplex sonography surveillance
initiated within 48 hours of infrainguinal angioplasty
and continued for more than 2 years failed to detect a
difference in patency of angioplasty sites between
those patients who had abnormal results of duplex
examinations and those whose examination results
were normal.s? Similarly, investigators have shown
that resting ABPI does not identify patients with sig-
nificant restenosis. Post-exercise ABPI measurement is
more likely to show the presence of haemodynam-
ically significant lesions."
Recommendation 99: Surveillance program for
aortoiliac transluminal angioplasty
Patients undergoing aortoiliac vascular reconstruc-
tion or transluminal angioplasty for lower extremi-
ty revascularisation should be entered into a sur-
veillance program consisting of:
• interval history (new symptoms)
• vascular examination of the leg with palpation of
proximal and outflow vessel pulses
• resting and, if possible, post-exercise ABPI
recording
Surveillance programs should be performed in the
immediate post-PTA period and at intervals for at
least 2 years.
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Critical Issue 41: Surveillance program for angio-
plasty and other endovascular produres
There is a need for confirmation that the surveil-
lance program suggested for vein bypass grafts is
also beneficial after endovascular procedures.
04.14.4
Management of a Failing Lower Extremity
Revascularisation
The identification of a failing lower extremity autoge-
nous bypass by duplex imaging surveillance frequent-
ly provides the physician with sufficient information
to plan intervention. This is especially true of in situ
saphenous vein bypass grafts,J.2.3A.5,6 The presence of
haemodynarnically significant stenoses within the
graft or the progression of a mild lesion to one of
haemodynamic significance should indicate the need
for intervention. Many techniques have been used
successfully to treat these lesions, including balloon
angioplasty, patch angioplasty, and segmental vein
resection and interposition vein graft. The interposi-
tion of a prosthetic segment into a vein graft is of
dubious value.
The detection of a decreasing resting or post-exer-
cise ABPI in a patient with a prosthetic infrainguinal
bypass should lead to angiographic assessment of the
patient. Because duplex imaging fails to adequately
image the flow surface of prosthetic grafts, interven-
tion requires a complete and detailed evaluation of the
inflow, prosthetic, and outflow vessels. Only then can
appropriate intervention be planned. Patients with
stenoses within the native inflow or outflow arteries
may be treated by conventional angioplasty or surgi-
cal techniques. Stenoses within the body of the pros-
thetic graft are best treated by direct surgical revision.
Angioplasty has not been of demonstrated benefit in
the treatment of these lesions.
A decrease in the resting or post-exercise ABPI in
patients who were treated by transluminal angioplas-
ty should be studied by angiography to determine the
feasibility of performing a redilation of the lesion.
Duplex imaging of lower-extremity angioplasty sites
may be of value for the assessment of lesions in
patients who do not clearly warrant intervention.
Patients who have had rapid restenosis of an anglo-
plasty site or who have required multiple repeat
angioplasties should be considered for surgical inter-
vention. The point at which a graft stenosis becomes
critical, that is, the point beyond which thrombosis is
very likely to occur, has not been determined. There
appears to be a transition from a low to high risk
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between a 50% and 75% stenosis.25.50 In addition,
whether velocity criteria from Duplex scanning or
anatomic criteria from angiography best identify the
critical risk point is debated. More research is needed
to settle this important issue.
Critical Issue 42: Intervention during surveillance
program
There is a need for further information to identify
what degree of lesionts) restenosis, as detected by
surveillance studies, must be corrected.
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lilt is the responsibility of every surgeon ... to moni-
tor his experience with care. Onlythose surgeons with
acceptable results are ultimately qualified."I Although
this quotation comes from an editorial regarding
carotid surgery, it is undoubtedly true for all kinds of
Eur J Vasc Endovasc Surg Vol 19 Supplement A, June 2000
vascular and endovascular procedures. Carefully per-
formed single-centre audits are obviously of value,
but larger registries enabling comparisons between
centres, between treatments, and the study of time
trends have an even higher impact and should be even
more reliable. (See also Recommendation 77, p SI50).
Besides specific registries, such as the Vietnam
Vascular Registry? a very early experience came from
the Cleveland Vascular Society, reporting a large-scale
computerised registration.' More recent registries
have been reported from the Society for Clinical
Vascular Surgery- and the Upstate New York Vascular
Society," More recent experiences come from
Scandinavia with the Swedish Vascular Registry
(SWEDVASq starting in 1987, followed by the FINN-
VASC, the Danish KARBASE, and the Norwegian
NORKAR.
An important difference between the Scandinavian
and North American registries reported above is that
the former are intended to cover entire countries.
Regarding SWEDVASC, this was accomplished from
early 1994 after a successive increase of the number of
hospitals from its initiation in 1987.6 Recently, experi-
ences have been presented from a New Zealand vas-
cular registry, from Northern Ireland and from The
Netherlands (personal communication).
D 4.15.1
Problems With Vascular Registry Data
Limitations may be that long-term results are not eas-
ily obtained. Both FINNVASC and the Danish registry
have found data after 30 days difficult to retrieve.7,8.9,IO
The Swedish Vascular Registry has a I-year follow-up
rate after surgery for chronic limb ischaemia of 92%,
whereas endovascular procedures are less frequently
reported. There is an apparent risk that patients not
followed-up are worse than those who are followed-
up. In a study of femoral distal bypass procedures,
12% were lost to follow-up. Compared with followed-
up patients, those lost to follow-up had mortality rates
of 29% versus 19% and patency rates of 43% versus
68%.11 Also, a Danish follow-up has convincingly
shown that patients lost to follow-up had a signifi-
cantly increased rate of graft thrombosis, limb ampu-
tation, and death." On average the I-year follow-up
rate in SWEDVASC now exceeds 90%. Longer-term
follow-up would be beneficial but is not realistic.
Conversely, in countries in which it is possible to con-
nect a national registry to a population registry, long-
term mortality rates would at least be achievable. This
has been used in studies based on outcome in the
SWEDVASC registry.13
